ADA 2026 Special: The full recap

The Pharma Closeout's full recap of the American Diabetes Association's 86th Scientific Sessions (New Orleans,June 5-8, 2026) - the meeting that ended the A1C-only era and reset what obesity medicine can do. Hosts Alex Mercer and Maya Patel walk every major readout, with the commercial read on each.Visit us at www.thepharmacloseout.comADA 2026, American DiabetesAssociation, diabetes, obesity, GLP-1, retatrutide, orforglipron, tirzepatide, semaglutide, CagriSema, survodutide, MASH, type 1 diabetes, tegoprubart,teplizumab, Dexcom, CGM, automated insulin delivery, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, AstraZeneca, Roche, Standards of Care, weight loss drugs,endocrinology, pharma, biotech, clinical trials